Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol^®-PM) in patients with solid tumorsLIM, W. T; TAN, E. H; TOH, C. K et al.Annals of oncology. 2010, Vol 21, Num 2, pp 382-388, issn 0923-7534, 7 p.Article

Preparing for first-in-man studies : the challenges for translational immunology post-TGN1412DAYAN, C. M; WRAITH, D. C.Clinical and experimental immunology (Print). 2008, Vol 151, Num 2, pp 231-234, issn 0009-9104, 4 p.Article

Safety issues in cell-based intervention trialsDAWSON, Liza; BATEMAN-HOUSE, Alison S; SCHILL, Kathryn E et al.Fertility and sterility. 2003, Vol 80, Num 5, pp 1077-1085, issn 0015-0282, 9 p.Article

Therapeutic Misconception, Misestimation, and Optimism in Participants Enrolled in Phase 1 TrialsPENTZ, Rebecca D; WHITE, Margaret; HARVEY, R. Donald et al.Cancer. 2012, Vol 118, Num 18, pp 4571-4578, issn 0008-543X, 8 p.Article

A Phase I Study to Assess the Feasibility and Oncologic Safety of Axillary Reverse Mapping in Breast Cancer PatientsBEDROSIAN, Isabelle; BABIERA, Gildy V; MITTENDORF, Elizabeth A et al.Cancer. 2010, Vol 116, Num 11, pp 2543-2548, issn 0008-543X, 6 p.Article

Phase 1 Pharmacokinetic and Drug-Interaction Study of Dasatinib in Patients With Advanced Solid TumorsJOHNSON, Faye M; AGRAWAL, Shruti; CHIAPPORI, Alberto A et al.Cancer. 2010, Vol 116, Num 6, pp 1582-1591, issn 0008-543X, 10 p.Article

Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitorSPARREBOOM, A; KEHRER, D. F. S; KLAREN, A et al.British journal of cancer. 2004, Vol 90, Num 8, pp 1508-1515, issn 0007-0920, 8 p.Article

A Phase 1 /Pharmacokinetic Study of Sunitinib in Combination With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Positive Patients With Cancer: AIDS Malignancy Consortium Trial AMC 061RUDEK, Michelle A; MOORE, Page C; HAIGENTZ, Missak et al.Cancer. 2014, Vol 120, Num 8, pp 1194-1202, issn 0008-543X, 9 p.Article

Phase 1 and Pharmacodynamic Trial of Everolimus in Combination With Cetuximab in Patients With Advanced CancerCIUNCI, Christine A; PERINI, Rodolfo F; DIVGI, Chaitanya R et al.Cancer. 2014, Vol 120, Num 1, pp 77-85, issn 0008-543X, 9 p.Article

A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumoursBOWLES, D. W; MA, W. W; HAUSMAN, D et al.British journal of cancer. 2013, Vol 109, Num 5, pp 1085-1092, issn 0007-0920, 8 p.Article

Timing of Palliative Care Referral and Symptom Burden in Phase 1 Cancer Patients: A Retrospective Cohort StudyHUI, David; PARSONS, Henrique; NGUYEN, Linh et al.Cancer. 2010, Vol 116, Num 18, pp 4402-4409, issn 0008-543X, 8 p.Article

Do Phase 1 Patients Have Greater Needs for Palliative Care Compared With Other Cancer Patients?FINLAY, Esmé; LU, Hien L; HENDERSON, Hope et al.Cancer. 2009, Vol 115, Num 2, pp 446-453, issn 0008-543X, 8 p.Article

Phase 1 Study of an Oxaliplatin and Etoposide Regimen in Pediatric Patients With Recurrent Solid TumorsMCGREGOR, Lisa M; SPUNT, Sheri L; SANTANA, Victor M et al.Cancer. 2009, Vol 115, Num 3, pp 655-664, issn 0008-543X, 10 p.Article

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumoursBLAGDEN, S. P; MOLIFE, L. R; HODGE, J. P et al.British journal of cancer. 2008, Vol 98, Num 5, pp 894-899, issn 0007-0920, 6 p.Article

A Phase 1 Trial of 2 Dose Schedules of ABT-510, an Antiangiogenic, Thrombospondin-1-mimetic Peptide, in Patients With Advanced CancerGORDON, Michael S; MENDELSON, David; CARR, Robert et al.Cancer. 2008, Vol 113, Num 12, pp 3420-3429, issn 0008-543X, 10 p.Article

Phase I and pharmacokinetic study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), using a weekly 30-minute intravenous infusion, in patients with advanced solid malignanciesBRAYBROOKE, J. P; BOVEN, E; BATES, N. P et al.Annals of oncology. 2003, Vol 14, Num 6, pp 913-921, issn 0923-7534, 9 p.Article

Dose proportionality and pharmacokinetics of extended-release (OROS^®) hydromorphone: A phase 1, open-label, randomized, crossover study in healthy Taiwanese subjectsVANDENBOSSCHE, Joris; RICHARDS, Henry M; CHIH CHERNG LU et al.International journal of clinical pharmacology and therapeutics. 2014, Vol 52, Num 3, pp 217-226, issn 0946-1965, 10 p.Article

Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation studyISAKOFF, S. J; WANG, D; CAMPONE, M et al.British journal of cancer. 2014, Vol 111, Num 11, pp 2058-2066, issn 0007-0920, 9 p.Article

REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumoursLEVY, C; ALLOUACHE, D; DIERAS, V et al.Annals of oncology. 2014, Vol 25, Num 12, pp 2351-2356, issn 0923-7534, 6 p.Article

Phase 1 Trial of Preoperative, Short-Course Carbon-Ion Radiotherapy for Patients With Resectable Pancreatic CancerSHINOTO, Makoto; YAMADA, Shigeru; YASUDA, Shigeo et al.Cancer. 2013, Vol 119, Num 1, pp 45-51, issn 0008-543X, 7 p.Article

Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trialsFREEMAN, G. A; KIMMELMAN, J; DANCEY, J et al.British journal of cancer. 2013, Vol 109, Num 4, pp 897-908, issn 0007-0920, 12 p.Article

Phase 1 Clinical Trials in 83 Patients With Pancreatic Cancer: The M. D. Anderson Cancer Center ExperienceVAKLAVAS, Christos; TSIMBERIDOU, Apostolia-Maria; WEN, Sijin et al.Cancer. 2011, Vol 117, Num 1, pp 77-85, issn 0008-543X, 9 p.Article

Phase 1 Dose-Escalation Trial of Tremelimumab Plus Sunitinib in Patients With Metastatic Renal Cell CarcinomaRINI, Brian I; STEIN, Mark; SHANNON, Pat et al.Cancer. 2011, Vol 117, Num 4, pp 758-767, issn 0008-543X, 10 p.Article

A safety grading scale to support dose escalation and define stopping rules for healthy subject first-entry-into-man studies: Some points to consider from the French Club Phase I^* working groupSIBILLE, Michel; PATAT, Alain; CAPLAIN, Henri et al.British journal of clinical pharmacology. 2010, Vol 70, Num 5, pp 736-748, issn 0306-5251, 13 p.Article

Phase 1 and Pharmacokinetic Study of Concurrent Carboplatin and Irinotecan in Subjects Aged 1 to 21 Years With Refractory Solid TumorsLEVY, Adam S; MEYERS, Paul A; WEXLER, Leonard H et al.Cancer. 2009, Vol 115, Num 1, pp 207-216, issn 0008-543X, 10 p.Article